4.5 Review

Idiopathic Anaphylaxis

Journal

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jaip.2014.02.012

Keywords

Anaphylaxis; Idiopathic anaphylaxis; Mast cell activating syndrome; Mast cell activating disorder; Galactose-alpha-1,3-galactose

Funding

  1. Mylan
  2. Sanofi

Ask authors/readers for more resources

Idiopathic anaphylaxis is a perplexing problem that accounts for approximately 30% to 60% of cases of anaphylaxis in ambulatory adults and perhaps 10% of cases in children. Advances in our knowledge of idiopathic anaphylaxis have occurred over the past decade with the elucidation of mast cell activating disorders and the discovery of episodes of anaphylaxis caused by galactose-alpha-1,3-galactose. Most patients do well because fatalities can usually be prevented with proper therapy, and many individuals, for reasons not understood, undergo spontaneous remission. (C) 2014 American Academy of Allergy, Asthma & Immunology

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available